A subsidiary of Sun Pharmaceutical Industries Ltd has acquired 14.6% stake in US-based scPharmaceuticals Inc. for $13 million in cash, the Indian company said in a stock exchange filing on Friday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
